Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Abbott Laboratories (ABT) has a market cap of $203.52 billion USD. According to our data, Abbott Laboratories is ranked No.59 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $203.52 B |
4.28%
|
| Dec 31, 2024 | $195.16 B |
4.81%
|
| Dec 29, 2023 | $186.20 B |
2.26%
|
| Dec 30, 2022 | $182.08 B |
-20.68%
|
| Dec 31, 2021 | $229.56 B |
30.53%
|
| Dec 31, 2020 | $175.87 B |
28.04%
|
| Dec 31, 2019 | $137.36 B |
22.08%
|
| Dec 31, 2018 | $112.51 B |
29.06%
|
| Dec 29, 2017 | $87.18 B |
52.03%
|
| Dec 30, 2016 | $57.34 B |
-12.32%
|
| Dec 31, 2015 | $65.40 B |
1.87%
|
| Dec 31, 2014 | $64.20 B |
20.08%
|
| Dec 31, 2013 | $53.46 B |
23.96%
|
| Dec 31, 2012 | $43.13 B |
20.30%
|
| Dec 30, 2011 | $35.85 B |
21.78%
|
| Dec 31, 2010 | $29.44 B |
-8.27%
|
| Dec 31, 2009 | $32.10 B |
4.58%
|
| Dec 31, 2008 | $30.69 B |
-2.49%
|
| Dec 31, 2007 | $31.47 B |
18.04%
|
| Dec 29, 2006 | $26.66 B |
26.86%
|
| Dec 30, 2005 | $21.02 B |
-13.48%
|
| Dec 31, 2004 | $24.29 B |
17.80%
|
| Dec 31, 2003 | $20.62 B |
19.27%
|
| Dec 31, 2002 | $17.29 B |
-26.73%
|
| Dec 31, 2001 | $23.60 B |
17.08%
|
| Dec 29, 2000 | $20.15 B |
35.84%
|
| Dec 31, 1999 | $14.84 B |
-24.79%
|
| Dec 31, 1998 | $19.73 B |
51.84%
|
| Dec 31, 1997 | $12.99 B |
31.97%
|
| Dec 31, 1996 | $9.84 B |
24.56%
|
| Dec 29, 1995 | $7.90 B |
30.45%
|
| Dec 30, 1994 | $6.06 B |
12.98%
|
| Dec 31, 1993 | $5.36 B |
0.02%
|
| Dec 31, 1992 | $5.36 B |
-10.10%
|
| Dec 31, 1991 | $5.96 B |
56.10%
|
| Dec 31, 1990 | $3.82 B |
35.23%
|
| Dec 29, 1989 | $2.83 B |
44.71%
|
| Dec 30, 1988 | $1.95 B |
2.21%
|
| Dec 31, 1987 | $1.91 B |
7.04%
|
| Dec 31, 1986 | $1.78 B |
36.06%
|
| Dec 31, 1985 | $1.31 B |
68.21%
|
| Dec 31, 1984 | $0.78 B |
-5.16%
|
| Dec 30, 1983 | $0.82 B |
19.29%
|
| Dec 31, 1982 | $0.69 B |
43.52%
|
| Dec 31, 1981 | $0.48 B |
-4.42%
|
| Dec 31, 1980 | $0.50 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$344.10 B |
0.003 M
|
USA
|
 Medtronic
MDT
|
$113.11 B |
-0.218 B
|
Ireland
|
 Pfizer
PFE
|
$149.69 B |
-1.275 B
|
USA
|
 Merck
MRK
|
$242.90 B |
-0.007 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$114.88 B |
-0.811 B
|
USA
|
 Amgen
AMGN
|
$147.39 B |
-0.333 B
|
USA
|
 Gilead Sciences
GILD
|
$115.25 B |
-0.604 B
|
USA
|
 Eli Lilly
LLY
|
$670.90 B |
3.292 B
|
USA
|
 Novartis
NVS
|
$197.89 B |
-1.499 B
|
Switzerland
|
 Sanofi
SNY
|
$129.28 B |
-0.313 B
|
France
|
 GlaxoSmithKline
GSK
|
$68.73 B |
-0.194 B
|
UK
|
 AstraZeneca
AZN
|
$211.74 B |
0.000 M
|
UK
|
 Thermo Fisher Scientific
TMO
|
$221.36 B |
0.006 M
|
USA
|
| Market Cap | = | ABT Stock Price | * | ABT Shares Outstanding |
| = | $117.34 | * | 1.73 B | |
| = | $203.52 B |